7Baggers

We provide you with 20 years of free, institutional-grade data for ALDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALDX. Explore the full financial landscape of ALDX stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Alfieri MichaelOpen Market Purchase2,500$5.32025-08-15
Machatha StephenSale-22,073$5.15$113,7132025-08-13
PERCEPTIVE ADVISORS LLCSale-3,400,000$1.42$4,828,0002025-04-07
Miller-Rich NancyOpen Market Purchase922$12.812024-10-21
Machatha StephenSale-16,041$4.74$75,9752024-08-14
Greenberg BruceSale-10,834$4.74$51,3132024-08-14
Machatha StephenSale-11,537$3.16$36,5032024-04-17
Greenberg BruceSale-13,201$3.41$44,9682024-04-17
PERCEPTIVE ADVISORS LLCOpen Market Purchase177,993$4.672024-04-08
PERCEPTIVE ADVISORS LLCOpen Market Purchase504,272$3.252024-04-03
Greenberg BruceSale-13,201$3.41$44,9682024-03-12
Machatha StephenSale-29,768$3.41$101,4022024-03-12
Brady Todd CSale-183,238$3.27$599,8302024-03-12
PERCEPTIVE ADVISORS LLCSale-2,756,499$1.6$4,410,3982023-10-18
Phillips Gary M.Derivatives Exercise5,4372023-09-11
Brady Todd CSale-73,807$7.22$532,8872023-09-11
Brady Todd CDerivatives Exercise273,0582023-09-11
Walker NealDerivatives Exercise9,6042023-08-24
Bronstein BenDerivatives Exercise9,6042023-06-29
Brady Todd CGrant, award...etc238,7502023-03-02
PERCEPTIVE ADVISORS LLCOpen Market Purchase115,000$7.52022-08-11
PERCEPTIVE ADVISORS LLCOpen Market Purchase97,000$7.242022-08-10
PERCEPTIVE ADVISORS LLCOpen Market Purchase141,000$6.952022-08-09
PERCEPTIVE ADVISORS LLCOpen Market Purchase95,100$6.172022-08-08
PERCEPTIVE ADVISORS LLCOpen Market Purchase100,000$5.842022-08-05
PERCEPTIVE ADVISORS LLCOpen Market Purchase412,406$5.592022-08-04
PERCEPTIVE ADVISORS LLCOpen Market Purchase144,185$5.052022-08-03
PERCEPTIVE ADVISORS LLCOpen Market Purchase222,123$5.032022-08-02
PERCEPTIVE ADVISORS LLCOpen Market Purchase119,392$52022-08-01
Machatha StephenGrant, award...etc185,6052022-07-19
Greenberg BruceGrant, award...etc126,0872022-07-19
JOYCE MARTIN JOSEPHOpen Market Purchase4,323$3.482022-06-27
Brady Todd COpen Market Purchase17,700$3.362022-06-27
Greenberg BruceInitial2022-05-13
Brady Todd CGrant, award...etc250,0002022-04-01
Reed JoshuaGrant, award...etc93,3222022-04-01
Machatha StephenGrant, award...etc64,3952022-04-01
Login to see more insider transactions
The information provided in this report about ALDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Aldeyra Therapeutics, Inc
(NASDAQ:ALDX) 

ALDX stock logo

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and alle...

Founded: 2004
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends